-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
-
Tesla Inc. (TSLA $431.44)
- $431.44 P/E (TTM): 291.67X Cap: $1.43T
- View TSLA Profile
- View Questions on TSLA
Q: Elon has made some strange comments lately:
1. Nobody needs to save money anymore because somehow robots will benefit everyone and we don’t need it?
2. Apparently tsla is getting into the robotic surgery business. Is this a concern for isrg? Are they likely to put isrg on the innovation scrap heap and how can we know?
1. Nobody needs to save money anymore because somehow robots will benefit everyone and we don’t need it?
2. Apparently tsla is getting into the robotic surgery business. Is this a concern for isrg? Are they likely to put isrg on the innovation scrap heap and how can we know?
-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
-
Vertex Pharmaceuticals Incorporated (VRTX $461.14)
- $461.14 P/E (TTM): 30.86X Cap: $112.16B
- View VRTX Profile
- View Questions on VRTX
-
AbbVie Inc. (ABBV $216.15)
- $216.15 P/E (TTM): 163.39X Cap: $382.02B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $218.01)
- $218.01 P/E (TTM): 21.11X Cap: $525.73B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $1,078.52)
- $1,078.52 P/E (TTM): 50.8X Cap: $984.41B
- View LLY Profile
- View Questions on LLY
-
Merck & Company Inc. (MRK $111.11)
- $111.11 P/E (TTM): 14.39X Cap: $271.65B
- View MRK Profile
- View Questions on MRK
-
iShares Biotechnology ETF (IBB $175.16)
- $175.16 P/E (TTM): 21.3X Cap: $8.75B
- View IBB Profile
- View Questions on IBB
-
IDEXX Laboratories Inc. (IDXX $696.46)
- $696.46 P/E (TTM): 56.73X Cap: $55.61B
- View IDXX Profile
- View Questions on IDXX
-
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 16.12X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
-
Incyte Corporation (INCY $104.67)
- $104.67 P/E (TTM): 17.54X Cap: $20.54B
- View INCY Profile
- View Questions on INCY
-
Catalyst Pharmaceuticals Inc. (CPRX $24.13)
- $24.13 P/E (TTM): 13.2X Cap: $2.87B
- View CPRX Profile
- View Questions on CPRX
-
Gilead Sciences CDR (CAD Hedged) (GILD $26.44)
- $26.44 P/E (TTM): 328.71X Cap: $210.04B
- View GILD Profile
- View Questions on GILD
Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare
-
Intuitive Surgical Inc. (ISRG $523.69)
- $523.69 P/E (TTM): 69.68X Cap: $185.64B
- View ISRG Profile
- View Questions on ISRG
-
Alphabet CDR (CAD Hedged) (GOOG $53.10)
- $53.10 P/E (TTM): 40.07X Cap: $5.48T
- View GOOG Profile
- View Questions on GOOG
Q: Which stock will have more growth going forward: GOOG or ISRG. I understand they are in different sectors and I am not concerned about volatility?
Thank you for your service!
Thank you for your service!
Insiders
Share Information
SEC Filings
News and Media